AdvaCare is a GMP manufacturer of Ciprofloxacin infusions.
Ciprofloxacin infusion is indicated for the treatment of following infections: lower respiratory tract infections due to gram-negative bacteria, exacerbations of chronic obstructive pulmonary disease, broncho-pulmonary infections in cystic fibrosis or in bronchiectasis, pneumonia, chronic suppurative otitis media, acute exacerbation of chronic sinusitis (especially if these are caused by gram-negative bacteria), urinary tract infections, genital tract infections, epididymo-orchitis including cases due to susceptible neisseria gonorrhoeae, pelvic inflammatory disease, infections of the gastro-intestinal tract (e.g. travellers` diarrhea), intra-abdominal infections, infections of the skin and soft tissue caused by gram-negative bacteria, malignant external otitis, infections of the bones and joints, inhalation anthrax (post-exposure prophylaxis and curative treatment).
Ciprofloxacin may also be used to treat severe infections in children and adolescents.
Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.
As with all pharmaceuticals some unwanted effects can occur from the use of ciprofloxacin infusions. Always consult a doctor or healthcare professional for medical advice before use.
Common side effects include: dizziness, tremor, headache, tiredness, seizures, hallucinations, confusion, abdominal discomfort, renal and hepatic impairment as well as crystalluria and hematuria.
Seek medical attention if any adverse effects occur.
For a comprehensive list of all possible effects, consult your doctor.
If any symptom persists or gets worse, or you notice any other symptom, then please call your doctor immediately.